✦ LIBER ✦

Potential role of human papillomavirus in the development of subsequent primary in situ and invasive cancers among cervical cancer survivors

✍ Scribed by Appathurai Balamurugan; Faruque Ahmed; Mona Saraiya; Carol Kosary; Molly Schwenn; Vilma Cokkinides; Lisa Flowers; Lori A. Pollack

Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 149 KB
Volume: 113
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.23746

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Distribution of human papillomavirus gen

Distribution of human papillomavirus genotypes among cervical intraepithelial neoplasia and invasive cancers in Macao

✍ Thazin Hlaing; Yuk-Ching Yip; Karry L.K. Ngai; Heong-Ting Vong; Sio-In Wong; Wen 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

## Abstract Macao is a densely populated city situated in East Asia where a relatively high prevalence of human papillomavirus (HPV) types 52 and 58 has been reported in women with invasive cervical cancer. To provide data for a population‐specific estimation on the impact of HPV vaccines, paraffin

Human papillomavirus testing and cervica

Human papillomavirus testing and cervical cytology in primary screening for cervical cancer among women in rural China: Comparison of sensitivity, specificity, and frequency of referral

✍ Lisa M. Moy; Fang-Hui Zhao; Long-Yu Li; Jun-Fei Ma; Qing-Ming Zhang; Feng Chen; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 431 KB 👁 2 views

## Abstract The causal relationship between persistent high‐risk human papillomavirus infection and cervical cancer is widely accepted. HR‐HPV DNA testing, alone or in combination with Pap smear testing, may have a role in primary screening. The screening results (VIA, VILI, Pap, and HR‐HPV DNA) of

The potential impact of human papillomav

The potential impact of human papillomavirus vaccination in contemporary cytologically screened populations may be underestimated: An observational retrospective analysis of invasive cervical cancers

✍ Ned Powell; Adam Boyde; Amanda Tristram; Sam Hibbitts; Alison Fiander 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 78 KB 👁 1 views

## Abstract The aim of this study was to determine the proportion of invasive cervical cancers attributable to human papillomavirus (HPV) types 16 and 18 in a contemporary, cytologically well‐screened UK population. This was achieved in a retrospective observational analysis by HPV typing 453 archi

Evaluation of oncogenic human papillomav

Evaluation of oncogenic human papillomavirus RNA and DNA tests with liquid-based cytology in primary cervical cancer screening: The FASE study

✍ Joseph Monsonego; Michael G. Hudgens; Laurent Zerat; Jean-Claude Zerat; Kari Syr 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 335 KB 👁 2 views

The APTIMA V R HPV Assay (AHPV) allows detection of 14 high-risk human papillomavirus (HPV) RNA types in cervical specimens. Until present, the assay has been compared to HPV DNA tests only in triage settings. Herein, we compare AHPV with a DNA assay (Hybrid Capture V R 2; HC2) and liquid-based cyto

Randomized controlled trial of human pap

Randomized controlled trial of human papillomavirus testing versus Pap cytology in the primary screening for cervical cancer precursors: Design, methods and preliminary accrual results of the Canadian cervical cancer screening trial (CCCaST)

✍ Marie-Hélène Mayrand; Eliane Duarte-Franco; François Coutlée; Isabel Rodrigues; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 403 KB 👁 1 views

## Abstract Since infection with oncogenic human papillomavirus (HPV) has been considered a necessary cause of cervical cancer, tests for oncogenic HPV types have been proposed as adjuncts or replacements to Pap cytology. We designed the Canadian Cervical Cancer Screening Trial (CCCaST) to compare